AMG479 (Pancreatic Cancer) - Analysis and Forecasts to 2020

AMG479 (Pancreatic Cancer) - Analysis and Forecasts to 2020

Summary

GlobalData’s pharmaceuticals report, “AMG479 (Pancreatic Cancer) - Analysis and Forecasts to 2020” provides AMG479 sales forecasts for the US. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Pancreatic Cancer market. This report is built using data and information sourced from GlobalData’s proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

Note: This is a on-demand report and will be delivered within 7 business days (excluding weekends) of the purchase.

Scope

- Therapy area profile including patient population for the US
- Analysis and review of AMG479 including sales data
- Qualitative and quantitative assessment of market space
- Analysis of the trends, drivers and restraints shaping and defining the markets
- In-depth analysis of AMG479 including efficacy, safety, pricing, competition and other details which influence its sales potential
- Detailed sales forecasts for 2015-2020 for AMG479 in the US

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
- Examine the historical sales performance of a drug in seven major markets
- Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets

1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 Pancreatic Cancer 4
2.2 Pancreatic Cancer Market 4
2.3 Epidemiology 5
2.4 Etiology 7
2.4.1 Cigarette Smoking 7
2.4.2 Age 7
2.4.3 Gender 8
2.4.4 Family History 8
2.4.5 Other Factors 9
2.5 GlobalData Market Forecasts Report Guidance 10
3 Pancreatic Cancer: Market Characterization 11
3.1 Pancreatic Cancer Market 11
3.2 Pancreatic Cancer Market Forecasts and CAGR 11
3.3 Drivers for Pancreatic Cancer Market 12
3.3.1 High Prevalence 12
3.3.2 High Incidence 12
3.3.3 Large Unmet Need 13
4 Tumor-Node-Metastases (TNM) Classification of Pancreatic Cancer 14
5 AMG479 17
5.1 Introduction 17
5.2 Mechanism of Action 17
5.3 Clinical Studies 17
5.4 Factors Affecting Sales of AMG479 17
5.4.1 Pancreatic Cancer Market 17
5.4.2 Approval in EU and Japan 17
5.4.3 Better Efficacy 18
5.4.4 Unfavourable Toxicity Profile 18
5.5 Drug Evaluation 18
5.5.1 Drug Risk Benefit Score 18
5.5.2 Intensity of Competition 19
5.6 Sales Forecasts 19
5.6.1 Target Patient Pool of AMG479 19
5.6.2 Dosing 20
5.6.3 Market Penetration 20
5.6.4 Annual Cost of Therapy 20
5.6.5 Sales Projections of AMG479 21
6 Pancreatic Cancer Market: Appendix 22
6.1 Market Definitions 22
6.2 Abberiviations 22
6.3 Research Methodology 22
6.3.1 Coverage 22
6.3.2 Secondary Research 22
6.3.3 Forecasting 23
6.3.4 Number of Patients Approved to take the Drug 23
6.3.5 Net Penetration of Drug 23
6.3.6 Net Annual Dosing 25
6.3.7 Annual Cost of Therapy 25
6.3.8 Primary Research 25
6.3.9 Expert Panels 25
6.4 Contact Us 25
6.5 Disclaimer 26
6.6 Sources 26